AstraZeneca's COVID-19 antibody cocktail clears first step for registration in Australia

AstraZeneca's antibody cocktail against COVID-19 received its first nod for registration in Australia, the country's medical regulatory body said on Tuesday. The Therapeutic Goods Administration said it granted provisional determination to the Anglo-Swedish drugmaker last week for its antibody cocktail, EVUSHELD, the first protective shot other than vaccines against COVID-19. The regulator said the provisional determination is the first step in the process, adding that it now expects AstraZeneca to submit an application for provisional registration shortly.